| Lastest Insider Transactions Of Janux Therapeutics, Inc. ( JANX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-05-01 | Sell | 3,333 | 32.03 | 106,745 | 2025-05-02 20:00:06 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-05-01 | Option Exercise | 3,333 | 4.21 | 14,032 | 2025-05-02 20:00:06 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-04-21 | Sell | 3,334 | 30.00 | 100,020 | 2025-04-23 20:00:05 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-04-21 | Option Exercise | 3,334 | 4.21 | 14,036 | 2025-04-23 20:00:05 |
| JANX | Janux Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior 10% Owner | 2025-03-05 | Buy | 824,041 | 30.75 | 25,342,964 | 2025-03-07 18:05:32 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-03-03 | Sell | 3,334 | 32.15 | 107,174 | 2025-03-05 20:00:13 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-03-03 | Option Exercise | 3,334 | 4.21 | 14,036 | 2025-03-05 20:00:13 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-02-03 | Sell | 3,334 | 42.29 | 140,999 | 2025-02-05 20:00:05 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-02-03 | Option Exercise | 3,334 | 4.21 | 14,036 | 2025-02-05 20:00:05 |
| JANX | Janux Therapeutics, Inc. | Campbell David Alan | President and CEO | 2025-01-07 | Sell | 5,000 | 60.00 | 300,004 | 2025-01-08 20:00:05 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2025-01-02 | Sell | 13,334 | 54.88 | 731,785 | 2025-01-03 17:10:04 |
| JANX | Janux Therapeutics, Inc. | Campbell David Alan | President and CEO | 2024-12-24 | Sell | 25,000 | 56.19 | 1,404,805 | 2024-12-27 20:00:05 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2024-12-19 | Option Exercise | 9,881 | 20.24 | 199,985 | 2024-12-20 18:25:16 |
| JANX | Janux Therapeutics, Inc. | Campbell David Alan | President and CEO | 2024-12-03 | Sell | 15,000 | 67.00 | 1,005,000 | 2024-12-03 20:00:05 |
| JANX | Janux Therapeutics, Inc. | Campbell David Alan | President and CEO | 2024-11-25 | Sell | 25,000 | 51.60 | 1,289,879 | 2024-11-27 20:00:06 |
| JANX | Janux Therapeutics, Inc. | Campbell David Alan | President and CEO | 2024-10-28 | Sell | 25,000 | 53.54 | 1,338,559 | 2024-10-30 19:30:06 |
| JANX | Janux Therapeutics, Inc. | Lichter Jay | 10% Owner | 2024-09-13 | Sell | 3,815 | 46.68 | 178,084 | 2024-10-24 16:15:07 |
| JANX | Janux Therapeutics, Inc. | Lichter Jay | 10% Owner | 2024-09-13 | Option Exercise | 3,815 | 17.29 | 65,951 | 2024-10-24 16:15:07 |
| JANX | Janux Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior 10% Owner | 2024-10-18 | Buy | 1,200,000 | 44.75 | 53,700,000 | 2024-10-22 16:20:04 |
| JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% Owner | 2024-10-16 | Sell | 1,673,128 | 46.30 | 77,472,368 | 2024-10-18 18:51:26 |
| JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% Owner | 2024-10-16 | Option Exercise | 12,284 | 18.07 | 222,010 | 2024-10-18 18:51:26 |
| JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% Owner | 2024-09-26 | Sell | 307,779 | 46.96 | 14,452,394 | 2024-09-30 20:49:38 |
| JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% Owner | 2024-09-26 | Option Exercise | 2,671 | 18.07 | 48,260 | 2024-09-30 20:49:38 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2024-09-27 | Sell | 50,000 | 45.96 | 2,297,755 | 2024-09-27 19:32:58 |
| JANX | Janux Therapeutics, Inc. | Meyer Andrew Hollman | Chief Business Officer | 2024-09-27 | Option Exercise | 50,000 | 4.21 | 210,500 | 2024-09-27 19:32:58 |
| JANX | Janux Therapeutics, Inc. | DiRaimondo Thomas | Chief Scientific Officer | 2024-09-27 | Sell | 5,000 | 46.34 | 231,716 | 2024-09-27 19:31:52 |
| JANX | Janux Therapeutics, Inc. | Campbell David Alan | President and CEO | 2024-09-27 | Sell | 25,000 | 46.31 | 1,157,641 | 2024-09-27 19:30:51 |
| JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% Owner | 2024-09-10 | Sell | 451,091 | 46.89 | 21,153,620 | 2024-09-12 20:42:19 |
| JANX | Janux Therapeutics, Inc. | Lichter Jay | Directior 10% Owner | 2024-06-03 | Sell | 1,500,000 | 54.75 | 82,125,000 | 2024-06-05 19:25:27 |
| JANX | Janux Therapeutics, Inc. | Reardon Tighe | Acting Chief Financial Officer | 2024-06-03 | Sell | 822,721 | 54.75 | 45,043,976 | 2024-06-05 19:23:19 |
| JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% Owner | 2024-06-03 | Sell | 1,500,000 | 54.75 | 82,125,000 | 2024-06-05 19:19:57 |
| JANX | Janux Therapeutics, Inc. | Reardon Tighe | Acting Chief Financial Officer 10% Owner | 2023-11-13 | Buy | 849,854 | 5.87 | 4,988,643 | 2023-11-15 16:48:17 |
| JANX | Janux Therapeutics, Inc. | Lichter Jay | Directior 10% Owner | 2023-11-13 | Buy | 849,854 | 5.87 | 4,988,643 | 2023-11-15 16:46:54 |
| JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% Owner | 2023-11-13 | Buy | 849,854 | 5.87 | 4,988,643 | 2023-11-13 19:11:13 |
| JANX | Janux Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior 10% Owner | 2023-07-19 | Buy | 495,008 | 12.46 | 6,167,800 | 2023-07-21 16:31:07 |
